News Detail
Boston, 29 March 2024: Using patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for moderate-to-severe kidney injury after receiving the chemotherapy drug cisplatin in the largest, first generalizable study of ......
View Details
Source : EurekaAlert
risk prediction model
moderate-to-severe kidney injury
chemotherapy drug cisplatin
Related News
- Geometric machine learning method promises to accelerate precision drug development (20-01-2025)
- AI-Designed Antivenom Counteracts Toxins from Snakebites (17-01-2025)
- Researchers develop Quantum Dots that can help detect Antibiotics (17-01-2025)
- Feeding your good gut bacteria through fibre in diet may boost body against infections (13-01-2025)
- New combination drug offers treatment against intestinal worms: Lancet (13-01-2025)
- Researchers bypass the liver, delivering genetic drugs to the target location (01-01-2025)
- Study uses AI to cast light on harmful drug-drug interactions (16-12-2024)
- IIT-BHU developing med device with potential to cure sclerosis (28-11-2024)
- Three widely used BP medicines Combo, five times more effective than current drugs (19-11-2024)
- More than half of patients with rheumatic, musculoskeletal disease use OTC supplements: Study (18-11-2024)